SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar

被引:39
|
作者
Al-Thani, Mohamed H. [1 ]
Farag, Elmoubasher [1 ]
Bertollini, Roberto [1 ]
Al Romaihi, Hamad Eid [1 ]
Abdeen, Sami [2 ]
Abdelkarim, Ashraf [2 ]
Daraan, Faisal [1 ]
Ismail, Ahmed Ibrahim Hashim Elhaj [1 ]
Mostafa, Nahid [1 ]
Sahl, Mohamed [1 ,2 ]
Suliman, Jinan [2 ]
Tayar, Elias [2 ]
Kasem, Hasan Ali [3 ]
Agsalog, Meynard J. A. [3 ]
Akkarathodiyil, Bassam K. [3 ]
Alkhalaf, Ayat A. [3 ]
Alakshar, Mohamed Morhaf M. H. [3 ]
Al-Qahtani, Abdulsalam Ali A. H. [3 ]
Al-Shedifat, Monther H. A. [3 ]
Ansari, Anas [3 ]
Ataalla, Ahmad Ali [3 ]
Chougule, Sandeep [3 ]
Gopinathan, Abhilash K. K., V [3 ]
Poolakundan, Feroz J. [3 ]
Ranbhise, Sanjay U. [3 ]
Saefan, Saed M. A. [3 ]
Thaivalappil, Mohamed M. [3 ]
Thoyalil, Abubacker S. [3 ]
Umar, Inayath M. [3 ]
Al Kanaani, Zaina [2 ]
Al Khal, Abdullatif [2 ]
Al Kuwari, Einas [2 ]
Butt, Adeel A. [2 ,4 ]
Coyle, Peter [2 ,5 ,6 ]
Jeremijenko, Andrew [2 ]
Kaleeckal, Anvar Hassan [2 ]
Latif, Ali Nizar [2 ]
Shaik, Riyazuddin Mohammad [2 ]
Rahim, Hanan F. Abdul [7 ]
Yassine, Hadi M. [6 ,8 ]
Nasrallah, Gheyath K. [6 ,8 ]
Al Kuwari, Mohamed Ghaith [9 ]
Chaghoury, Odette [10 ]
Chemaitelly, Hiam [11 ,12 ]
Abu-Raddad, Laith J. [4 ,11 ,12 ]
机构
[1] Minist Publ Hlth, Doha, Qatar
[2] Hamad Med Corp, Doha, Qatar
[3] QatarRed Crescent Soc, Doha, Qatar
[4] Cornell Univ, Dept Populat Hlth Sci, Weill Cornell Med, New York, NY 10021 USA
[5] Queens Univ, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland
[6] Qatar Univ, Biomed Res Ctr, Doha, Qatar
[7] Qatar Univ, Coll Hlth Sci, QU Hlth, Doha, Qatar
[8] Qatar Univ, Coll Hlth Sci, Dept Biomed Sci, QU Hlth, Doha, Qatar
[9] Primary Hlth Care Corp, Doha, Qatar
[10] Cornell Univ, Weill Cornell Med Qatar, Doha, Qatar
[11] Cornell Univ, Qatar Fdn Educ City, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Doha, Qatar
[12] Cornell Univ, Qatar Fdn Educ City, WHO Collaborating Ctr Dis Epidemiol Analyt HIV AI, Weill Cornell Med Qatar, Doha, Qatar
来源
OPEN FORUM INFECTIOUS DISEASES | 2021年 / 8卷 / 08期
关键词
COVID-19; immunity; Qatar; SARS-CoV-2; seroprevalence; COVID-19; SEROPREVALENCE; REGION;
D O I
10.1093/ofid/ofab221
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Qatar experienced a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic that disproportionately affected the craft and manual worker (CMW) population, who comprise 60% of the total population. This study aimed to assess ever and/or current infection prevalence in this population. Methods. A cross-sectional population-based survey was conducted during July 26 to September 09, 2020, to assess both anti-SARS-CoV-2 positivity through serological testing and current infection positivity through polymerase chain reaction (PCR) testing. Associations with antibody and PCR positivity were identified through regression analyses. Results. The study included 2641 participants, 69.3% of whom were <40 years of age. Anti-SARS-CoV-2 positivity was 55.3% (95% CI, 53.3%-57.3%) and was significantly associated with nationality, geographic location, educational attainment, occupation, and previous infection diagnosis. PCR positivity was 11.3% (95% CI, 9.9%-12.8%) and was significantly associated with nationality, geographic location, occupation, contact with an infected person, and reporting 2 or more symptoms. Infection positivity (antibody and/or PCR positive) was 60.6% (95% CI, 58.6%-62.5%). The proportion of antibody-positive CMWs who had a prior SARS-CoV-2 diagnosis was 9.3% (95% CI, 7.9%-11.0%). Only seven infections were ever severe, and only 1 was ever critical-an infection severity rate of 0.5% (95% CI, 0.2%-1.0%). Conclusions. Six in every 10 CMWs in Qatar have been infected, suggestive of reaching the herd immunity threshold. Infection severity was low, with only 1 in every 200 infections progressing to be severe or critical. Only 1 in every 10 infections had been previously diagnosed, which is suggestive of mostly asymptomatic or mild infections.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] SARS-CoV-2 herd immunity of the Kyrgyz population in 2021
    Popova, Anna Y.
    Kasymov, Omor T.
    Smolenski, Vyacheslav Y.
    Smirnov, Vyacheslav S.
    Egorova, Svetlana A.
    Nurmatov, Zuridin S.
    Milichkina, Anzhelika M.
    Suranbaeva, Gulmira S.
    Kuchuk, Tatiana E.
    Khamitova, Irina, V
    Zueva, Elena, V
    Ivanov, Valery A.
    Nuridinova, Zhanylai N.
    Derkenbaeva, Aisuluu A.
    Drobyshevskaya, Victoria G.
    Sattarova, Gulsun Z.
    Kaliev, Marat T.
    Gubanova, Alexandra, V
    Zhimbaeva, Oyuna B.
    Razumovskaya, Alexandra P.
    Verbov, Vyacheslav N.
    Likhachev, Ivan, V
    Krasnov, Alexey, V
    Totolian, Areg A.
    [J]. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2022, 211 (04) : 195 - 210
  • [2] SARS-CoV-2 herd immunity of the Kyrgyz population in 2021
    Anna Y. Popova
    Omor T. Kasymov
    Vyacheslav Y. Smolenski
    Vyacheslav S. Smirnov
    Svetlana A. Egorova
    Zuridin S. Nurmatov
    Anzhelika M. Milichkina
    Gulmira S. Suranbaeva
    Tatiana E. Kuchuk
    Irina V. Khamitova
    Elena V. Zueva
    Valery A. Ivanov
    Zhanylai N. Nuridinova
    Aisuluu A. Derkenbaeva
    Victoria G. Drobyshevskaya
    Gulsun Z. Sattarova
    Marat T. Kaliev
    Alexandra V. Gubanova
    Oyuna B. Zhimbaeva
    Alexandra P. Razumovskaya
    Vyacheslav N. Verbov
    Ivan V. Likhachev
    Alexey V. Krasnov
    Areg A. Totolian
    [J]. Medical Microbiology and Immunology, 2022, 211 : 195 - 210
  • [3] SARS-CoV-2: from herd immunity to hybrid immunity
    David Goldblatt
    [J]. Nature Reviews Immunology, 2022, 22 : 333 - 334
  • [4] Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
    Anderson, Roy M.
    Vegvari, Carolin
    Truscott, James
    Collyer, Benjamin S.
    [J]. LANCET, 2020, 396 (10263): : 1614 - 1616
  • [5] Achieving and sustaining herd immunity to SARS-CoV-2
    Bolotin, Shelly
    Wilson, Sarah
    Murti, Michelle
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (28) : E1089 - E1089
  • [6] Achievement and maintenance of herd immunity to SARS-CoV-2
    Bolotin, Shelly
    Wilson, Sarah
    Murti, Michelle
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (32) : E1279 - E1280
  • [7] Herd Immunity and Implications for SARS-CoV-2 Control
    Omer, Saad B.
    Yildirim, Inci
    Forman, Howard P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (20): : 2095 - 2096
  • [8] Immunity to SARS-CoV-2 infection
    Pepper, Marion
    [J]. IMMUNOLOGICAL REVIEWS, 2022, 309 (01) : 5 - 7
  • [9] SARS-CoV-2: from herd immunity to hybrid immunity COMMENT
    Goldblatt, David
    [J]. NATURE REVIEWS IMMUNOLOGY, 2022, 22 (06) : 333 - 334
  • [10] Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhao
    Moura da Silva, Antonio Augusto
    Goncalves Lima-Neto, Lidio
    Pedrozo e Silva de Azevedo, Conceicao de Maria
    Melo da Costa, Lea Marcia
    Barbosa Martins Braganca, Maylla Luana
    Barros Filho, Allan Kardec Duailibe
    Wittlin, Bernardo Bastos
    de Souza, Bruno Feres
    Alves de Oliveira, Bruno Luciano Carneiro
    de Carvalho, Carolina Abreu
    Abreu Fonseca Thomaz, Erika Barbara
    Simoes-Neto, Eudes Alves
    Leite Junior, Jamesson Ferreira
    Sousa Santos Cosme, Lecia Maria
    Garcia Campos, Marcos Adriano
    de Sousa Queiroz, Rejane Christine
    Costa, Sergio Souza
    de Carvalho, Vitoria Abreu
    Ferreira Simoes, Vanda Maria
    de Britt e Alves, Maria Teresa Seabra Soares
    dos Santos, Alcione Miranda
    [J]. REVISTA DE SAUDE PUBLICA, 2020, 54 : 1 - 14